Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HIV vaccine therapy.

D L Birx1, R R Redfield

  • 1Department of Retroviral Research, Walter Reed Army Institute of Research, Rockville, MD 20850.

International Journal of Immunopharmacology
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Very Early Cytomegalovirus Infection After Renal Transplantation: A Single-Center 20-Year Perspective.

Virology : research and treatment·2019
Same author

Impact of ureteral stricture and treatment choice on long-term graft survival in kidney transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2018
Same author

A Single-Center Experience With Tacrolimus LCP (Envarsus XR) in Pancreas Transplant Recipients.

The Annals of pharmacotherapy·2017
Same author

Does DCD Donor Time-to-Death Affect Recipient Outcomes? Implications of Time-to-Death at a High-Volume Center in the United States.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016
Same author

Diagnosis and Treatment of Pancreas Rejection.

Current transplantation reports·2015
Same author

Clinical performance of non-radioactive assays for HIV-1 DNA amplified by the polymerase chain reaction.

World journal of microbiology & biotechnology·2014
Same journal

Induction of surface antigen CD69 expression in T-lymphocytes following exposure to actinomycin D.

International journal of immunopharmacology·2003
Same journal

Skewed differentiation of bone marrow CD34+ cells of tumor bearers from dendritic toward monocytic cells, and the redirection of differentiation toward dendritic cells by 1alpha,25-dihydroxyvitamin D3.

International journal of immunopharmacology·2003
Same journal

Differential effect of a single high dose of the tricyclic antidepressant imipramine on interleukin-1beta and tumor necrosis factor-alpha secretion following an in vivo lipopolysaccharide challenge in rats.

International journal of immunopharmacology·2003
Same journal

Pharmacokinetic properties, induction of interferon, and efficacy of selected 5-halo-6-phenyl pyrimidinones, bropirimine analogues, in a model of severe experimental autoimmune encephalomyelitis.

International journal of immunopharmacology·2003
Same journal

[3H]Paroxetine binding to human peripheral lymphocyte membranes of patients with major depression before and after treatment with fluoxetine.

International journal of immunopharmacology·2003
Same journal

Report of the second annual walker's cay colloqium on cancer vaccines and immunotherapy, March 8-11, 2000.

International journal of immunopharmacology·2001
See all related articles

Post-infection vaccination with an HIV envelope vaccine broadens immune responses against HIV. This approach is safe and feasible in adults with early HIV infection, potentially altering the disease

Area of Science:

  • Immunology
  • Virology
  • Vaccinology

Background:

  • The mechanisms for controlling HIV infection after initial exposure are not fully understood.
  • Natural HIV infection leads to weak immune responses against the virus's envelope proteins (gp120).
  • Limited antibody and T-cell responses against gp120 are observed in individuals with natural HIV infection.

Purpose of the Study:

  • To investigate the feasibility and impact of post-infection vaccination using HIV envelope-derived products.
  • To broaden host-directed immune responses against HIV after infection.
  • To assess the safety and immunogenicity of an HIV envelope-based vaccine in early HIV infection.

Main Methods:

  • Demonstrated scientific feasibility of post-infection vaccination with an HIV envelope vaccine.

Related Experiment Videos

  • Evaluated the vaccine's ability to induce seroconversion to gp120 epitopes (C1, C2, C3).
  • Assessed the induction of T-cell recognition to gp160 and cytotoxic T-cell responses to envelope peptides.

    • Main Results:

    • Post-infection vaccination successfully broadened immune responses to HIV envelope components.
    • The vaccine demonstrated safety and immunogenicity in adult patients with early HIV infection.
    • An ongoing Phase II trial (rgp160, MGS) is evaluating the vaccine's potential to modify HIV's natural course.

    Conclusions:

    • Post-infection vaccination is a scientifically feasible strategy to enhance anti-HIV immune responses.
    • The HIV envelope vaccine shows promise for improving immune control in individuals with early HIV infection.
    • Further research is exploring the role of post-infection immunization in HIV immunoregulatory relevance.